Test Bank for Medical Surgical Nursing: Concepts for Interprofessional Collaborative Care 10th Edition - Care of Patients with Hematologic Problems Related

Review Test Bank for Medical Surgical Nursing: Concepts for Interprofessional Collaborative Care 10th Edition - Care of Patients with Hematologic Problems related questions and content

A client with multiple myeloma demonstrates worsening bone density on diagnostic scans. About what drug does the nurse plan to teach this client?

  • A. Zoledronic acid (Zometa)
  • B. Denosumab (Xgeva)
  • C. Bortezomib (Velcade)
  • D. Lenalidomide (Revlimid)
Correct Answer: A

Rationale: Zoledronic acid is a bisphosphonate commonly used to treat bone loss in multiple myeloma by inhibiting osteoclast activity, thus improving bone density. Denosumab is another option for bone health but is less commonly used in this context. Bortezomib and lenalidomide are used for treating multiple myeloma but primarily target the cancer cells, not specifically bone density.